Does New Hampshire Medicaid cover Wegovy and Zepbound in 2026?

No, not since Jan 1, 2026. As of Oct 23, 2026, New Hampshire Medicaid no longer covers GLP-1 drugs for obesity alone.

What this covers

Coverage of GLP-1 drugs for obesity alone under New Hampshire’s fee-for-service Medicaid drug rules, as the state publishes them. The plan decides each request.

New Hampshire’s rule

In plain words

Coverage ended in 2026

No longer covered when prescribed solely for weight loss, from Jan 1, 2026.

Source

State Medicaid pharmacy vendor (Prime Therapeutics): NH Division of Medicaid Services provider notice, Oct 9, 2025 (opens in new tab). Checked Oct 23, 2026.

Federal Medicaid law lets a state exclude these drugs only “when used for anorexia, weight loss, or weight gain”; their use for type 2 diabetes is not on that list, though a state may require prior authorization. Social Security Act §1927(d)(1)(A) and (d)(2)(A), 42 U.S.C. 1396r-8(d) (opens in new tab).

What changed

Questions this page answers

Does New Hampshire Medicaid cover Wegovy and Zepbound for weight loss?

No, not since Jan 1, 2026. As of Oct 23, 2026, New Hampshire Medicaid no longer covers GLP-1 drugs for obesity alone. No longer covered when prescribed solely for weight loss, from Jan 1, 2026.

Has New Hampshire’s rule changed recently?

Jan 1, 2026: New Hampshire Medicaid stopped covering GLP-1s prescribed solely for weight loss.

Where does this information come from?

From New Hampshire Medicaid’s pharmacy vendor (Prime Therapeutics): NH Division of Medicaid Services provider notice, Oct 9, 2025, read on Oct 23, 2026. Federal Medicaid law lets a state exclude these drugs only “when used for anorexia, weight loss, or weight gain”; their use for type 2 diabetes is not on that list, though a state may require prior authorization.

Kymata Health reads each state’s own Medicaid documents. See every state on the map.

Educational only. Not medical advice. Some links earn us a commission: kymatahealth.com/affiliate-disclosure.